The Actalyke® Activated Clotting Time test system takes a bold step forward in the management of heparin anticoagulation.
Actalyke analyzers are for use at the point of care during cardiopulmonary bypass, cardiac catheterization, angioplasty, hemodialysis and other procedures where heparin monitoring with accurate ACT results is needed. For enhanced user flexibility and cost-effectiveness. Actalyke instruments and test tubes are interchangeable with other ACT systems using electromagnetic clot detection principles.
The MINI II is the simplest, least expensive ACT instrument available, yet it retains high sensitivity, 2-point clot detection for greatest reliability. Performance, linearity and CVs parallel larger Actalyke analyzers. It’s ideal for use in the catheterization, dialysis or the surgical suite. Optional battery pack available.
• 6” Footprint – The MINI II features a very small footprint, but has a very large high visibility screen. Operation of the MINI II is extremely simple. Just insert the ACT reagent tube containing whole blood and push the button.
• Full Cross-Compatibility – The MINI II is fully compatible with all ACT tubes. Helena offers a full line of Actalyke ACT tubes, including traditional glass bead, kaolin and celite, plus new MAX-ACT
Tests: Whole Blood Activated Clotting Time (ACT). Accepts Actalyke ACT Tubes with celite, kaolin, glass-bead activators; MAX-ACT Tubes with blended activators; all International Technidyne Hemochron® tubes
Measurement Range: 0-1500 seconds
Incubation Temperature: 36.5ºC – 37.5ºC (97.7ºF – 99.5ºF)
Dimensions: 6.1”W x 4.8”H x 6.3”L (15.5 x 12.2 x 16.0 cm)
Display: 3.2 x 1″ (8 x 2.54 cm)
Weight (with printer): 5.3 lbs. (2.4 kg) (with battery):
Line Voltage: 47-63 Hz, 85-265 V A/C (Battery optional – DC)
Environment: 15ºC to 30ºC (59 to 86ºF)
Data Transfer Capability: Printer option available for hard copy
CLIA Classification: Non-waived